The immunogenetics of resistance to malaria

Proceedings of the Association of American Physicians

Volumn 111, Issue 4, 1999, Pages 272-277

  Hill, A V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Coevolution; Human leukocyte antigen; Plasmodium; Polygenic; Polymorphism; Tumor necrosis factor

Indexed keywords

DNA POLYMORPHISM; GENETIC LINKAGE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE GENE; IMMUNOGENETICS; INFECTION RESISTANCE; MALARIA; PLASMODIUM; REVIEW;

EID: 0032814653     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99234.x     Document Type: Review

References (35)

1. 1 James S.P., Nicol W.D., Shute P.G. A study of induced malignant tertian malaria. Proc. Royal Soc. Med. 25: 1153 1186, 1932.
2. 2 Comstock G.W. Tuberculosis in twins: A re‐analysis of the Prophit survey. Am. Rev. Respir. Dis. 117: 621 624, 1978.
3. 3 Jepson A.P., Banya W.A., Sisay‐Joof F., et al. Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J. Infect Dis. 172: 316 319, 1995.
4. 4 McGuffin P. & Huckle P. Simulation of Mendelism revisited: The recessive gene for attending medical school. Am. J. Hum. Genet. 46: 994 999, 1990.
5. 5 Abel L., Cot M., Mulder L., et al. Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am. J. Hum. Genet. 50: 1308 1317, 1992.
6. 6 Modiano D., Petrarca V., Sirima B.S., et al. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc. Natl. Acad. Sci. U.S.A. 93: 13206 13211, 1996.
7. 7 Jepson A., Banya W., Sisay‐Joof F., et al. Quantification of the relative contribution of major histocompatibility complex (MHC) and non‐MHC genes to human immune responses to foreign antigens. Infect Immun. 65: 872 876, 1997.
8. 8 Jepson A., Sisay‐Joof F., Banya W., et al. Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. Br. Med. J. 315: 96 97, 1997.
9. 9 Garcia A., Marquet S., Bucheton B., et al. Linkage analysis of blood Plasmodium falciparum levels: Interest of the 5q31‐q33 chromosome region. Am. J. Trop. Med. Hyg. 58: 705 709, 1998.
10. 10 Piazza A., Mayr W.R., Contu L., et al. Genetic and population structure of four Sardinian villages. Ann. Hum. Genet. 49: 47 63, 1985.
11. 11 Hill A.V., Allsopp C.E., Kwiatkowski D., et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595 600, 1991.
12. 12 Hill A.V., Yates S.N., Allsopp C.E., et al. Human leukocyte antigens and natural selection by malaria. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 346: 379 385, 1994.
13. 13 Hill A.V., Elvin J., Willis A.C., et al. Molecular analysis of the association of HLA‐B53 and resistance to severe malaria. Nature 360: 434 439, 1992.
14. 14 Davenport M. & Hill A.V.S. Reverse immunogenetics: From HLA‐disease associations to vaccine candidates. Mol. Med. Today 2: 38 45, 1996.
15. 15 McGuire W., Hill A.V., Allsopp C.E., et al. Variation in the TNF‐alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508 510, 1994.
16. 16 Gilbert S.C., Plebanski M., Harris S.J., et al. A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 15: 1280 1284, 1997.
17. 17 Davenport M.P., Quinn C.L., Chicz R.M., et al. Naturally processed peptides from two disease‐resistance‐associated HLA‐ DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA‐DR beta chain. Proc. Natl. Acad. Sci. U.S.A. 92: 6567 6571, 1995.
18. 18 Thursz M.R., Kwiatkowski D., Allsopp C.E., et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 332: 1065 1069, 1995.
19. 19 Riley E.M., Olerup O., Bennett S., et al. MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Int. Immunol. 4: 1055 1063, 1992.
20. 20 Kwiatkowski D., Hill A.V., Sambou I., et al. TNF concentration in fatal cerebral, non‐fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201 1204, 1990.
21. 21 Wilson A.G., Symons J.A., McDowell T.L., et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94: 3195 3199, 1997.
22. 22 Fernandez‐Reyes D., Craig A.G., Kyes S.A., et al. A high frequency African coding polymorphism in the N‐terminal domain of ICAM‐1 predisposing to cerebral malaria in Kenya. Hum. Mol. Genet. 6: 1357 1360, 1997.
23. 23 Bellamy R., Kwiatkowski D., Hill A.V.S. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans. R. Soc. Trop. Med. Hyg. 92: 312 316, 1998.
24. 24 Turner M.W. Mannose‐binding lectin: The pluripotent molecule of the innate immune system. Immunol. Today 17: 532 540, 1996.
25. 25 Lipscombe R.J., Sumiya M., Hill A.V., et al. High frequencies in African and non‐African populations of independent mutations in the mannose binding protein gene. Hum. Mol. Genet. 1: 709 715, 1992.
26. 26 Bellamy R., Ruwende C., McAdam K.P., et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q.J.M. 91: 13 18, 1998.
27. 27 Miller L.H., Mason S.J., Clyde D.F., et al. The resistance factor to Plasmodium vivax in blacks. The Duffy‐blood‐group genotype, FyFy. N. Engl. J. Med. 295: 302 304, 1976.
28. 28 Tournamille C., Colin Y., Cartron J.P., et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy‐negative individuals. Nat.Genet. 10: 224 228, 1995.
29. 29 Horuk R., Chitnis C.E., Darbonne W.C., et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182 1184, 1993.
30. 30 Williams T.N., Maitland K., Bennett S., et al. High incidence of malaria in alpha‐thalassaemic children. Nature 383: 522 525, 1996.
31. 31 Gilbert S.C., Plebanski M., Gupta S., et al. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279: 1173 1177, 1998.
32. 32 Murphy P.M. Molecular mimicry and the generation of host defense protein diversity. Cell 72: 823 826, 1993.
33. 33 Weeks D.E. & Lathrop G.M. Polygenic disease: Methods for mapping complex disease traits. Trends Genet. 11: 513 519, 1995.
34. 34 Risch N. & Merikangas K. The future of genetic studies of complex human diseases. Science 273: 1516 1517, 1996.
35. 35 Van Hensbroek M.B., Palmer A., Onyiorah E., et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 174: 1091 1097, 1996.